The spectrum of aldolase B (ALDOB) mutations and the prevalence of hereditary fructose intolerance in Central Europe.

Standard

The spectrum of aldolase B (ALDOB) mutations and the prevalence of hereditary fructose intolerance in Central Europe. / Santer, René; Rischewski, Johannes; von Weihe, Michaela; Niederhaus, Marko; Schneppenheim, Sonja; Baerlocher, Kurt; Kohlschütter, Alfried; Muntau, Ania; Posselt, Hans-Georg; Steinmann, Beat; Schneppenheim, Reinhard.

In: HUM MUTAT, Vol. 25, No. 6, 6, 2005, p. 594.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Santer, R, Rischewski, J, von Weihe, M, Niederhaus, M, Schneppenheim, S, Baerlocher, K, Kohlschütter, A, Muntau, A, Posselt, H-G, Steinmann, B & Schneppenheim, R 2005, 'The spectrum of aldolase B (ALDOB) mutations and the prevalence of hereditary fructose intolerance in Central Europe.', HUM MUTAT, vol. 25, no. 6, 6, pp. 594. <http://www.ncbi.nlm.nih.gov/pubmed/15880727?dopt=Citation>

APA

Santer, R., Rischewski, J., von Weihe, M., Niederhaus, M., Schneppenheim, S., Baerlocher, K., Kohlschütter, A., Muntau, A., Posselt, H-G., Steinmann, B., & Schneppenheim, R. (2005). The spectrum of aldolase B (ALDOB) mutations and the prevalence of hereditary fructose intolerance in Central Europe. HUM MUTAT, 25(6), 594. [6]. http://www.ncbi.nlm.nih.gov/pubmed/15880727?dopt=Citation

Vancouver

Santer R, Rischewski J, von Weihe M, Niederhaus M, Schneppenheim S, Baerlocher K et al. The spectrum of aldolase B (ALDOB) mutations and the prevalence of hereditary fructose intolerance in Central Europe. HUM MUTAT. 2005;25(6):594. 6.

Bibtex

@article{e0d61f1e063d4184b3467c9fa2b899b3,
title = "The spectrum of aldolase B (ALDOB) mutations and the prevalence of hereditary fructose intolerance in Central Europe.",
abstract = "We investigated the molecular basis of hereditary fructose intolerance (HFI) in 80 patients from 72 families by means of a PCR-based mutation screening strategy, consisting of heteroduplex analysis, restriction enzyme digest, DNA single strand electrophoresis, and direct sequencing. For a subset of patients mutation screening with DHPLC was established which turned out to be as fast and as sensitive as the more conventional methods. Fifteen different mutations of the aldolase B (ALDOB) gene were identified in HFI patients. As in smaller previous studies, p.A150P (65%), p.A175D (11%) and p.N335K (8%) were the most common mutated alleles, followed by c.360_363delCAAA, p.R60X, p.Y204X, and c.865delC. Eight novel mutations were identified in eight families with HFI: a small indel mutation (c.1044_1049delTTCTGGinsACACT), two small deletions (c.345_372del28; c.841_842delAC), two splice site mutations (c.113-1G>A, c.799+2T>A), one nonsense mutation (c.612T>G (p.Y204X)), and two missense mutations (c.532T>C (p.C178R), c.851T>C (p.L284P)). By mutation screening for the three most common ALDOB mutations by DHPLC in 2,000 randomly selected newborns we detected 21 heterozygotes. Based on these data and after correction for less common and private ALDOB mutations, HFI prevalence in central Europe is estimated to be 1:26,100 (95% confidence interval 1: 12,600-79,000).",
author = "Ren{\'e} Santer and Johannes Rischewski and {von Weihe}, Michaela and Marko Niederhaus and Sonja Schneppenheim and Kurt Baerlocher and Alfried Kohlsch{\"u}tter and Ania Muntau and Hans-Georg Posselt and Beat Steinmann and Reinhard Schneppenheim",
year = "2005",
language = "Deutsch",
volume = "25",
pages = "594",
journal = "HUM MUTAT",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "6",

}

RIS

TY - JOUR

T1 - The spectrum of aldolase B (ALDOB) mutations and the prevalence of hereditary fructose intolerance in Central Europe.

AU - Santer, René

AU - Rischewski, Johannes

AU - von Weihe, Michaela

AU - Niederhaus, Marko

AU - Schneppenheim, Sonja

AU - Baerlocher, Kurt

AU - Kohlschütter, Alfried

AU - Muntau, Ania

AU - Posselt, Hans-Georg

AU - Steinmann, Beat

AU - Schneppenheim, Reinhard

PY - 2005

Y1 - 2005

N2 - We investigated the molecular basis of hereditary fructose intolerance (HFI) in 80 patients from 72 families by means of a PCR-based mutation screening strategy, consisting of heteroduplex analysis, restriction enzyme digest, DNA single strand electrophoresis, and direct sequencing. For a subset of patients mutation screening with DHPLC was established which turned out to be as fast and as sensitive as the more conventional methods. Fifteen different mutations of the aldolase B (ALDOB) gene were identified in HFI patients. As in smaller previous studies, p.A150P (65%), p.A175D (11%) and p.N335K (8%) were the most common mutated alleles, followed by c.360_363delCAAA, p.R60X, p.Y204X, and c.865delC. Eight novel mutations were identified in eight families with HFI: a small indel mutation (c.1044_1049delTTCTGGinsACACT), two small deletions (c.345_372del28; c.841_842delAC), two splice site mutations (c.113-1G>A, c.799+2T>A), one nonsense mutation (c.612T>G (p.Y204X)), and two missense mutations (c.532T>C (p.C178R), c.851T>C (p.L284P)). By mutation screening for the three most common ALDOB mutations by DHPLC in 2,000 randomly selected newborns we detected 21 heterozygotes. Based on these data and after correction for less common and private ALDOB mutations, HFI prevalence in central Europe is estimated to be 1:26,100 (95% confidence interval 1: 12,600-79,000).

AB - We investigated the molecular basis of hereditary fructose intolerance (HFI) in 80 patients from 72 families by means of a PCR-based mutation screening strategy, consisting of heteroduplex analysis, restriction enzyme digest, DNA single strand electrophoresis, and direct sequencing. For a subset of patients mutation screening with DHPLC was established which turned out to be as fast and as sensitive as the more conventional methods. Fifteen different mutations of the aldolase B (ALDOB) gene were identified in HFI patients. As in smaller previous studies, p.A150P (65%), p.A175D (11%) and p.N335K (8%) were the most common mutated alleles, followed by c.360_363delCAAA, p.R60X, p.Y204X, and c.865delC. Eight novel mutations were identified in eight families with HFI: a small indel mutation (c.1044_1049delTTCTGGinsACACT), two small deletions (c.345_372del28; c.841_842delAC), two splice site mutations (c.113-1G>A, c.799+2T>A), one nonsense mutation (c.612T>G (p.Y204X)), and two missense mutations (c.532T>C (p.C178R), c.851T>C (p.L284P)). By mutation screening for the three most common ALDOB mutations by DHPLC in 2,000 randomly selected newborns we detected 21 heterozygotes. Based on these data and after correction for less common and private ALDOB mutations, HFI prevalence in central Europe is estimated to be 1:26,100 (95% confidence interval 1: 12,600-79,000).

M3 - SCORING: Zeitschriftenaufsatz

VL - 25

SP - 594

JO - HUM MUTAT

JF - HUM MUTAT

SN - 1059-7794

IS - 6

M1 - 6

ER -